Peer Review reports
From: Rivaroxaban for the treatment of cerebral venous thrombosis
| Original Submission | ||
|---|---|---|
| 23 Nov 2020 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 22 Dec 2020 | Reviewed | Reviewer Report |
| 27 Dec 2020 | Reviewed | Reviewer Report - Ermioni Papageorgiou |
| 12 Jan 2021 | Author responded | Author comments - Zahra Mirzaasgari |
| Resubmission - Version 4 | ||
| 12 Jan 2021 | Submitted | Manuscript version 4 |
| 13 Jan 2021 | Author responded | Author comments - Zahra Mirzaasgari |
| Resubmission - Version 5 | ||
| 13 Jan 2021 | Submitted | Manuscript version 5 |
| 15 Jan 2021 | Author responded | Author comments - Zahra Mirzaasgari |
| Resubmission - Version 6 | ||
| 15 Jan 2021 | Submitted | Manuscript version 6 |
| 22 Jan 2021 | Reviewed | Reviewer Report |
| 29 Jan 2021 | Reviewed | Reviewer Report - Ermioni Papageorgiou |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 1 Feb 2021 | Editorially accepted | |
| 15 Feb 2021 | Article published | 10.1186/s12883-021-02091-1 |
You can find further information about peer review here.